
|Articles|November 12, 2021
Poll results: What pipeline presbyopia treatment are you most looking forward to?
Author(s)Brooke Henson, Editor
See our latest poll results
Advertisement
Optometry Times® polled our audience with the following question from October 22, 2021 to November 5, 2021:
The poll appeared on
81 ODs responded, in total. Of these:
- 1 responded "Orasis CSF-1"
- 5 responded "Allergan AGN-190584 drop"
- 3 responded "Eyenovia MicroLine drop"
- 1 responded "Presbyopia Therapies PRX-100"
- 2 responded "Ocuphire Pharma Nyxol"
- 69 responded "Visus Therapeutics Brimochol"
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement







































